Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cy A Stein

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nucleic Acids Research|March 10, 2018
Ammonium and arsenic trioxide are potent facilitators of oligonucleotide function when delivered by gymnosisXiaowei Zhang, Daniela Castanotto, Xueli Liu, et al.
Cancer Chemotherapy and Pharmacology|July 12, 2017
Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetateAzra Hussaini, Anthony J Olszanski, Cy A Stein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 11, 2016
Protein Kinase C-α is a Critical Protein for Antisense Oligonucleotide-mediated Silencing in Mammalian CellsDaniela Castanotto, Min Lin, Claudia Kowolik, et al.
Maturitas|November 20, 2012
Preoperative therapy for localized prostate cancer: a comprehensive overviewJensen Hu, JoAnn Hsu, Paulo G Bergerot, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
Antisense 2'-Deoxy, 2'-Fluroarabino Nucleic Acids (2'F-ANAs) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty AcidsNaira Souleimanian, Glen F Deleavey, Harris Soifer, et al.
The Journal of Biological Chemistry|December 17, 2011
Direct regulation of androgen receptor activity by potent CYP17 inhibitors in prostate cancer cellsHarris S Soifer, Naira Souleimanian, Sijian Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cellsLuba Benimetskaya, Johnathan C Lai, Anastasia Khvorova, et al.
Urologic Oncology|November 19, 2017
Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR studyCy A Stein, Richard Levin, Robert Given, et al.
Clinical Genitourinary Cancer|October 16, 2012
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivorsSumanta K Pal, Jonathan Yamzon, Virginia Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Comparison of d-g3139 and its enantiomer L-g3139 in melanoma cells demonstrates minimal in vitro but dramatic in vivo chiral dependencyJohnathan C Lai, Bob D Brown, Anatoliy M Voskresenskiy, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nucleic Acids Research|March 10, 2018
Ammonium and arsenic trioxide are potent facilitators of oligonucleotide function when delivered by gymnosisXiaowei Zhang, Daniela Castanotto, Xueli Liu, et al.
Cancer Chemotherapy and Pharmacology|July 12, 2017
Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetateAzra Hussaini, Anthony J Olszanski, Cy A Stein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 11, 2016
Protein Kinase C-α is a Critical Protein for Antisense Oligonucleotide-mediated Silencing in Mammalian CellsDaniela Castanotto, Min Lin, Claudia Kowolik, et al.
Maturitas|November 20, 2012
Preoperative therapy for localized prostate cancer: a comprehensive overviewJensen Hu, JoAnn Hsu, Paulo G Bergerot, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
Antisense 2'-Deoxy, 2'-Fluroarabino Nucleic Acids (2'F-ANAs) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty AcidsNaira Souleimanian, Glen F Deleavey, Harris Soifer, et al.
The Journal of Biological Chemistry|December 17, 2011
Direct regulation of androgen receptor activity by potent CYP17 inhibitors in prostate cancer cellsHarris S Soifer, Naira Souleimanian, Sijian Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cellsLuba Benimetskaya, Johnathan C Lai, Anastasia Khvorova, et al.
Urologic Oncology|November 19, 2017
Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR studyCy A Stein, Richard Levin, Robert Given, et al.
Clinical Genitourinary Cancer|October 16, 2012
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivorsSumanta K Pal, Jonathan Yamzon, Virginia Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Comparison of d-g3139 and its enantiomer L-g3139 in melanoma cells demonstrates minimal in vitro but dramatic in vivo chiral dependencyJohnathan C Lai, Bob D Brown, Anatoliy M Voskresenskiy, et al.
Pageof 3